Table 1.

Correlation of the expression of HOXD-AS1 with NSCLC clinical pathologic features

Characteristic	Number of patients	HOXD-AS1 mRNA expression
		High	Low	P-value
Gender				0.714
Male	50	29	21
Female	37	20	17
Age (years)				0.570
<65	35	21	14
≥65	52	28	24
Size of tumor (cm)				0.006*
≤ 3	45	19	26
>3	42	30	12
TNM stage				0.044*
I	14	4	10
II	26	14	12
III	47	31	16
Recurrence status				0.031*
Positive	48	32	16
Negative	39	17	22

Note:

^*Statistically significant difference (P<0.05).

Abbreviations: HOXD-AS1, HOXD cluster antisense RNA 1; NSCLC, non-small cell lung cancer.